# Patiromer and Diet/hrQoL in Chronic Dialysis

> **NCT06858280** · PHASE3 · RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 40 (estimated)

## Conditions studied

- Hyperkalaemia
- Chronic Kidney Disease Stage 3 and 4
- Dietary Intervention

## Interventions

- **DRUG:** Patiromer 8400 MG [Veltassa]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06858280
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06858280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06858280, "Patiromer and Diet/hrQoL in Chronic Dialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06858280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*